Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Orthofix Medical (OFIX) EBIT (2016 - 2025)

Orthofix Medical's EBIT history spans 16 years, with the latest figure at $494000.0 for Q4 2025.

  • For the quarter ending Q4 2025, EBIT rose 104.3% year-over-year to $494000.0, compared with a TTM value of -$81.4 million through Dec 2025, up 3.77%, and an annual FY2025 reading of -$81.4 million, up 3.77% over the prior year.
  • EBIT for Q4 2025 was $494000.0 at Orthofix Medical, up from -$17.0 million in the prior quarter.
  • The five-year high for EBIT was $89.6 million in Q4 2023, with the low at -$59.7 million in Q1 2023.
  • Average EBIT over 5 years is -$10.7 million, with a median of -$11.3 million recorded in 2022.
  • Biggest YoY gain for EBIT was 911.06% in 2023; the steepest drop was 1840.03% in 2023.
  • Tracing OFIX's EBIT over 5 years: stood at -$3.9 million in 2021, then crashed by 185.23% to -$11.0 million in 2022, then skyrocketed by 911.06% to $89.6 million in 2023, then tumbled by 112.81% to -$11.5 million in 2024, then soared by 104.3% to $494000.0 in 2025.
  • Per Business Quant, the three most recent readings for OFIX's EBIT are $494000.0 (Q4 2025), -$17.0 million (Q3 2025), and -$16.0 million (Q2 2025).